India
oi-Madhuri Adnal
New Delhi, Jan 03: India is likely to approve administering two doses of the AstraZeneca/Oxford vaccine and another locally developed by Bharat Biotech, each four weeks apart.
India’s Central Drugs Standards Control Organisation has already approved vaccines and a final decision is expected to be announced by the agency at a news conference today at 11 am.
An expert panel of India’s central drug authority on Saturday recommended granting permission for restricted emergency use of the indigenously developed COVID-19 vaccine Covaxin with certain conditions, a day after giving similar direction for the Oxford COVID-19 vaccine, sources said.
Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Internet connectivity, additional staff flagged during COVID-19 vaccine dry run
The Subject Expert Committee (SEC) on…
